Grant: $298,300 - National Institutes of Health - Sep. 21, 2009
No votes have been cast for this award yet
Award Description: Acute kidney injury has high morbidity and high mortality. There is no specific and effective treatment at the present time. Stem cells offer therapeutic potential for kidney disease. The goal of this application is to develop cell therapeutic agents from human umbilical cord blood-derived stem cells to treat acute kidney injury.
Project Description: The overall purpose of this work was to develop novel cell therapeutic agents to treat acute kidney injury. Based on our previous work on mouse bone marrow hematopoietic stem cells, we expect to be able to induced human umbilical cord blood-derived hematopoietic stem cells into renal cell fate and improve renal function and structure after transplantation into mice with acute kidney injury. This will be an important step toward stem cell based therapy for human kidney disease.
Jobs Summary: N/A (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Sep. 21, 2009. Help expand these official descriptions using the wiki below.